home All News open_in_new Full Article

SRF Poised For Revenue Boost From FY27 As Chemours Deal To Be Shot In The Arm: Analysts

SRF-Chemours Deal: DAM Capital said the partnership adds a credible medium-term growth driver for SRF and positions it better in the advanced FP space.


today 2 w. ago attach_file Politics

attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Economics


ID: 1301567031
Add Watch Country

arrow_drop_down